<DOC>
	<DOCNO>NCT01713361</DOCNO>
	<brief_summary>The purpose study : - To assess safety efficacy profile ISIS-FXIRx , include incidence bleeding VTE , patient undergoing total knee arthroplasty . - To compare efficacy safety profile ISIS-FXIRx patient achieve less equal 0.2 U/mL FXI activity level enoxaparin .</brief_summary>
	<brief_title>Active Comparator-Controlled Study Assess Safety Efficacy ISIS-FXIRx Total Knee Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<criteria>Give write informed consent Females must nonpregnant nonlactating , either surgically sterile postmenopausal . Males must surgically sterile , abstinent , engage sexual relation childbearing potential , must use contraception Undergoing elective , primary unilateral total knee arthroplasty Body weight &lt; 50 kg Patients increase risk bleeding . History intracranial intraocular bleeding . History gastrointestinal and/or endoscopically verified ulcer disease within past year . History excessive intra direct post operative bleeding traumatic spinal epidural anesthesia Brain , spinal , ophthalmologic surgery within past 3 month History clinically significant liver disease past year Screening laboratory result follow , clinically significant abnormality screen laboratory value aPTT PT INR &gt; ULN Factor IX activity &lt; LLN Factor VIII activity , vWF antigen Ristocetin cofactor activity &lt; 0.5 U/mL FXI activity &lt; 0.3 U/mL Urine protein blood persistently positive dipstick . In event positive test result , eligibility may confirm urine microscopy 24 hour urine protein measurement applicable ALT AST &gt; 1.5 x ULN Total bilirubin &gt; ULN Platelet count &lt; 150,000 ( history thrombocytopenia ) Hypersensitivity enoxaparin Anticipated concomitant use anticoagulants/antiplatelet agent NSAID nimesulide may affect study outcome drug influence coagulation ( except low dose aspirin short act NSAIDs halflife &lt; 20 hour ) least 7 day surgery treatment ISIS Rx . Anticipated use indwell intrathecal epidural catheter Anemia Screening Have condition could interfere patient participate completing study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>total knee arthroplasty</keyword>
	<keyword>Prophylaxis</keyword>
</DOC>